@timothyalex
Active 9 hours, 35 minutes ago-
Timothy Alexander wrote a new post 2 months ago
Five Below Raises Outlook After Sales Surge Fuels Earnings
PHILADELPHIA, PA — Five Below Inc. (NASDAQ: FIVE) raised its full-year sales and earnings outlook after reporting a sharp increase in first-quarter r […] -
Timothy Alexander wrote a new post 2 months ago
Vishay Targets EV Efficiency With New Power Module
MALVERN, PA — Vishay Intertechnology Inc. (NYSE: VSH) has introduced a new power module aimed at reducing space requirements and improving power e […] -
Timothy Alexander wrote a new post 2 months ago
pharosIQ Launches Data Platform as AI Reshapes B2B Sales
PHILADELPHIA, PA — pharosIQ has launched a new data-as-a-service offering aimed at helping businesses track buyer activity as artificial intelligence i […] -
Timothy Alexander wrote a new post 2 months ago
NextGen Pathology Adopts AI Platform to Expand Services
PHILADELPHIA, PA — NextGen Pathology has selected Proscia’s Concentriq digital pathology platform as part of a strategy to expand subspecialty d […] -
Timothy Alexander wrote a new post 2 months ago
ICYMI: Medicus Advances SkinJect Into Registrational Study for Rare Disorder
PHILADELPHIA, PA — Medicus Pharma Ltd. (NASDAQ: MDCX) has submitted a registrational study protocol to the U.S. Food and Drug Administration for its S […] -
Timothy Alexander wrote a new post 2 months ago
Madrigal Investors Focus on Rezdiffra Growth at Goldman Event
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) is set to present at the Goldman Sachs Global Healthcare Conference this week as i […] -
Timothy Alexander wrote a new post 2 months ago
Palvella Advances Rare Disease Drug Toward FDA Filing
WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) said it remains on track to submit a New Drug Application in the second half of 2026 for its l […] -
Timothy Alexander wrote a new post 2 months ago
Cabaletta Expands Autoimmune Strategy on Mid-Stage Data
PHILADELPHIA, PA — Cabaletta Bio (Nasdaq: CABA) reported new clinical data suggesting its lead CAR-T cell therapy candidate could support regulatory f […] -
Timothy Alexander wrote a new post 2 months ago
Mineralys Restructures Drug Economics With $500 Million Financing
RADNOR, PA — Mineralys Therapeutics (NASDAQ: MLYS) has agreed to eliminate future royalty obligations tied to its lead drug candidate lorundrostat w […] -
Timothy Alexander wrote a new post 2 months ago
Neuronetics Names Sales Chief, Grants Equity Incentive
MALVERN, PA — Neuronetics Inc. (NASDAQ: STIM) has appointed healthcare sales executive Robert Greene as senior vice president of sales and awarded h […] -
Timothy Alexander wrote a new post 2 months ago
Orchestra BioMed Grants Equity Awards to New Employees
NEW HOPE, PA — Orchestra BioMed Holdings Inc. (Nasdaq: OBIO) has granted stock options covering 85,500 shares to five newly hired employees, using an i […] -
Timothy Alexander wrote a new post 2 months ago
Callan Expands Advisory Services With Philanthropy Hire
PHILADELPHIA, PA — Callan Family Office has hired philanthropic strategist George Burnette as director of philanthropic consulting and wealth, e […] -
Timothy Alexander wrote a new post 2 months ago
Obesity Survey Finds Gap Between Treatment Support and Use
RADNOR, PA — New research comparing the views of primary care physicians and patients with obesity found broad acceptance of anti-obesity medications b […] -
Timothy Alexander wrote a new post 2 months ago
Angeion Names New CEO as Growth Strategy Enters Next Phase
PHILADELPHIA, PA — Angeion Group has appointed veteran legal information executive Bill Carter as chief executive officer, a leadership change that s […] -
Timothy Alexander wrote a new post 2 months ago
Palvella Set for Goldman Conference Amid Rare Disease Push
WAYNE, PA — Palvella Therapeutics (Nasdaq: PVLA) will present its development strategy to investors this week as the clinical-stage biotechnology c […] -
Timothy Alexander wrote a new post 2 months ago
SEED Advances Cancer Drug Into Human Trials, Targets Hard-to-Treat Tumors
KING OF PRUSSIA, PA — SEED Therapeutics has advanced its lead cancer drug candidate, ST-01156, into a first-in-human clinical trial, a step that will t […] -
Timothy Alexander wrote a new post 2 months ago
BLAST Robotics Explores Partnership Opportunities With Penn State Great Valley
MALVERN, PA — BLAST Robotics, a youth robotics program operated by Keystone STEM Alliance Inc., is exploring potential partnerships with Penn State G […] -
Timothy Alexander wrote a new post 2 months ago
London Britain Township: Inside Chester County's Most Carefully Preserved Rural Landscape
On a cool morning in southern Chester County, mist hangs low over the meadows of White Clay Creek. The only sounds are the rush of water over stone, […] -
Timothy Alexander wrote a new post 2 months ago
Quavo Report Highlights Dispute Resolution Performance Gaps
WILMINGTON, DE — Quavo Inc. recently released a new benchmarking study of fraud and dispute management programs, identifying key performance d […] -
Timothy Alexander wrote a new post 2 months ago
HHM Hotels Elevates Investment, Operations Chiefs to Managing Partners
PHILADELPHIA, PA — HHM Hotels has promoted Chief Investment Officer Shawn Tuli and Chief Operating Officer Dani Elhachem to managing partners, a l […] - Load More
